Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 20.59 USD 0.49% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Kiniksa Pharmaceuticals Ltd

Current Assets 301m
Cash & Short-Term Investments 218.8m
Receivables 20.5m
Other Current Assets 61.8m
Non-Current Assets 241.4m
PP&E 12.4m
Intangibles 16.8m
Other Non-Current Assets 212.3m
Current Liabilities 84.3m
Accounts Payable 7.4m
Accrued Liabilities 65.4m
Other Current Liabilities 11.5m
Non-Current Liabilities 23m
Other Non-Current Liabilities 23m

Balance Sheet
Kiniksa Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
56
46
72
47
114
123
123
108
Cash Equivalents
56
46
72
47
114
123
123
108
Short-Term Investments
0
0
235
187
209
60
68
98
Total Receivables
0
0
0
0
0
4
20
21
Accounts Receivables
0
0
0
0
0
4
20
21
Other Receivables
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
4
22
31
Other Current Assets
0
2
6
8
10
7
11
18
Total Current Assets
56
47
314
242
333
196
243
276
PP&E Net
0
0
6
8
11
8
7
13
PP&E Gross
0
0
6
8
11
8
7
13
Accumulated Depreciation
0
0
0
2
5
6
7
8
Intangible Assets
0
0
0
0
0
19
18
17
Other Long-Term Assets
0
0
2
5
6
9
191
220
Total Assets
57
N/A
48
-16%
322
+578%
255
-21%
350
+37%
233
-33%
460
+97%
526
+14%
Liabilities
Accounts Payable
0
1
11
6
1
2
8
8
Accrued Liabilities
2
16
31
22
31
41
33
47
Short-Term Debt
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
2
6
9
Total Current Liabilities
2
17
43
28
32
45
47
64
Long-Term Debt
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
1
6
3
17
24
Total Liabilities
2
N/A
17
+657%
43
+145%
29
-32%
38
+29%
48
+27%
64
+33%
87
+38%
Equity
Common Stock
80
120
0
0
0
0
0
0
Retained Earnings
26
91
194
356
518
675
492
478
Additional Paid In Capital
0
1
474
582
829
861
888
917
Other Equity
0
0
0
0
0
0
0
0
Total Equity
54
N/A
30
-44%
279
+828%
225
-19%
312
+38%
185
-41%
396
+114%
439
+11%
Total Liabilities & Equity
57
N/A
48
-16%
322
+578%
255
-21%
350
+37%
233
-33%
460
+97%
526
+14%
Shares Outstanding
Common Shares Outstanding
48
48
50
55
68
69
70
70

See Also

Discover More